Related papers: Anonymising Clinical Data for Secondary Use
Anonymization of graph-based data is a problem which has been widely studied over the last years and several anonymization methods have been developed. Information loss measures have been used to evaluate data utility and information loss…
Differential privacy is the gold standard for statistical data release. Used by governments, companies, and academics, its mathematically rigorous guarantees and worst-case assumptions on the strength and knowledge of attackers make it a…
The increasing availability of sensitive textual data has created an urgent need for robust de-identification methods that enable compliant data sharing while preserving downstream utility. This paper presents DeID-Clinic, a multi-layered…
We outline the constraints faced by operators when deciding to share de-identified data with researchers or policy makers. We describe a conservative approach that we have taken to harness the value of CDRs for infectious disease…
The exponential growth in the digitisation of services implies the handling and storage of large volumes of data. Businesses and services see data sharing and crossing as an opportunity to improve and produce new business opportunities. The…
Unlike other industries in which intellectual property is patentable, the financial industry relies on trade secrecy to protect its business processes and methods, which can obscure critical financial risk exposures from regulators and the…
Large, curated datasets are required to leverage speech-based tools in healthcare. These are costly to produce, resulting in increased interest in data sharing. As speech can potentially identify speakers (i.e., voiceprints), sharing…
The ongoing deprecation of third-party cookies by web browser vendors has sparked the proposal of alternative methods to support more privacy-preserving personalized advertising on web browsers and applications. The Topics API is being…
High-resolution individual geolocation data passively collected from mobile phones is increasingly sold in private markets and shared with researchers. This data poses significant security, privacy, and ethical risks: it's been shown that…
Clinical trial simulation (CTS) is critical in new drug development, providing insight into safety and efficacy while guiding trial design. Achieving realistic outcomes in CTS requires an accurately estimated joint distribution of the…
Recent advances in generative modelling have led many to see synthetic data as the go-to solution for a range of problems around data access, scarcity, and under-representation. In this paper, we study three prominent use cases: (1) Sharing…
How can agents exchange information to learn while protecting privacy? Healthcare centers collaborating on clinical trials must balance knowledge sharing with safeguarding sensitive patient data. We address this challenge by using…
In a technical treatment, this article establishes the necessity of transparent privacy for drawing unbiased statistical inference for a wide range of scientific questions. Transparency is a distinct feature enjoyed by differential privacy:…
The increasing availability of publicly shared electrocardiogram (ECG) data raises critical privacy concerns, as its biometric properties make individuals vulnerable to linkage attacks. Unlike prior studies that assume idealized adversarial…
Deep learning with medical data often requires larger samples sizes than are available at single providers. While data sharing among institutions is desirable to train more accurate and sophisticated models, it can lead to severe privacy…
Algorithms and technologies are essential tools that pervade all aspects of our daily lives. In the last decades, health care research benefited from new computer-based recruiting methods, the use of federated architectures for data…
We consider a user releasing her data containing some personal information in return of a service. We model user's personal information as two correlated random variables, one of them, called the secret variable, is to be kept private,…
This paper takes on the problem of automatically identifying clinically-relevant patterns in medical datasets without compromising patient privacy. To achieve this goal, we treat datasets as a black box for both internal and external users…
There is increasing interest in combining information from experimental studies, including randomized and single-group trials, with information from external experimental or observational data sources. Such efforts are usually motivated by…
Exploiting natural language processing in the clinical domain requires de-identification, i.e., anonymization of personal information in texts. However, current research considers de-identification and downstream tasks, such as concept…